Daymark Wealth Partners’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $928K | Buy |
5,751
+500
| +10% | +$80.7K | 0.04% | 272 |
|
|
2025
Q1 | $893K | Sell |
5,251
-55
| -1% | -$9.36K | 0.04% | 257 |
|
|
2024
Q4 | $882K | Buy |
5,306
+141
| +3% | +$23.4K | 0.04% | 254 |
|
|
2024
Q3 | $888K | Sell |
5,165
-98
| -2% | -$16.8K | 0.04% | 261 |
|
|
2024
Q2 | $810K | Buy |
5,263
+25
| +0.5% | +$3.85K | 0.04% | 266 |
|
|
2024
Q1 | $805K | Sell |
5,238
-201
| -4% | -$30.9K | 0.04% | 218 |
|
|
2023
Q4 | $860K | Hold |
5,439
| – | – | 0.05% | 197 |
|
|
2023
Q3 | $796K | Sell |
5,439
-1,003
| -16% | -$147K | 0.05% | 191 |
|
|
2023
Q2 | $987K | Sell |
6,442
-333
| -5% | -$51K | 0.07% | 169 |
|
|
2023
Q1 | $1.05M | Sell |
6,775
-30
| -0.4% | -$4.65K | 0.14% | 122 |
|
|
2022
Q4 | $1.05M | Buy |
+6,805
| New | +$1.05M | 0.19% | 90 |
|